ITEM 8.01 Other Events

APP Pharmaceuticals, Inc., a Delaware corporation ("APP"), is mailing to its stockholders a supplement, dated as of September 5, 2008, to the information statement/prospectus previously mailed to APP's stockholders in connection with the contemplated acquisition of APP by Fresenius SE (such supplement, the "information statement/prospectus supplement"). The information statement/prospectus supplement is attached as Exhibit 99.1 hereto and is incorporated herein by reference.

ITEM 9.01 Financial Statements and Exhibits.

(d) Exhibits

23.1 Consent of Lazard Frères & Co.

23.2 Consent of Goldman, Sachs & Co.

99.1 Information Statement/Prospectus Supplement, Dated September 5, 2008

---